Mcl-1 is one
The mcl-1 gene was originally identified as an early gene induced during differentiation of ML-1 myeloid leukemia cells (13) , and its encoded gene product contains structural features (i.e., the Bcl-2 homologous domains, BH1, BH2, and BH3) that categorize it as a member of the Bcl-2 family.
Mcl-1 appears to function at an apical step in many regulatory programs that control cell survival and death. Its synthesis is quickly stimulated after treatment of cells with many cytokines or other signals that lead to cell survival and/or differentiation (2, 6, 10, 11, 14, 25, 33) . On the other hand, when cells are deprived of survival factors, stimulated by genotoxic stress (e.g., UV irradiation), or infected by certain viruses, Mcl-1 synthesis is rapidly blocked, and the existing pool of Mcl-1 protein is quickly degraded (6, 8, 24) . Overexpression of Mcl-1 delays but does not prevent cells from undergoing apoptosis (6, 26, 38) , indicating that Mcl-1 enhances short-term cell survival. In the immune system, Mcl-1 protein levels are rapidly degraded in the extremely short-lived neutrophils that constitutively undergo apoptosis for the resolution of inflammation (1, 22) . Moreover, Mcl-1 levels were reported to decrease markedly in peripheral blood B lymphocytes when they undergo spontaneous apoptosis in vitro (19) , and the macrophage survival is strictly dependent on the expression of Mcl-1 (18) . A recent study by conditional ablation of Mcl-1 in the lymphoid system further indicates that Mcl-1 is required for the development and maintenance of B and T lymphocytes (25) . Lastly, Mcl-1 appears to be extremely important for early embryo development, since Mcl-1-null embryos die at the periimplantation stage (27) . Taken together, these studies indicate that proper regulation of Mcl-1 levels is pivotal to the success of many developmental processes, as well as of the various defense responses of the host system.
Cytokine stimulation of Mcl-1 expression is rapid but transient (6) . This is mainly because Mcl-1 proteins and mRNA are both extremely labile and are quickly degraded after the initial synthesis step (6, 34) . The extremely labile nature of the Mcl-1 protein itself and the fact that the Mcl-1 level is a critical determinant in various cell survival pathways suggest that cellular processes that regulate Mcl-1 stability are as important as those that regulate Mcl-1 synthesis. Although transcriptional stimulation of Mcl-1 synthesis in response to various stimuli has been well documented (6, 30, 31 ; see also reference 7 for a recent review), the regulation of Mcl-1 stability has been hardly explored.
Translationally controlled tumor protein (TCTP) has been identified in a wide range of eukaryotes, including fungus, yeast, insects, plants, and mammals (3, 20, 28, 36) . The extremely high degree of sequence conservation during evolution suggests that TCTP plays an essential role in the development of various organisms (28) . Although TCTP was implicated in the human allergic response (20) , apoptosis regulation (15) , and various other growth-related functions (9, 29, 35) , the biological roles of this protein remain elusive.
In the present study, by using a yeast two-hybrid approach, we identified that TCTP was one cellular factor that interacted with Mcl-1, a result consistent with that recently reported by Zhang et al. (37) . However, in contrast to their conclusion that Mcl-1 acts as a chaperone of TCTP (fortilin) (37), we found that TCTP bound to Mcl-1 and modulated the stability and antiapoptotic activity of Mcl-1. Furthermore, we demonstrated that TCTP stabilized Mcl-1 via interfering with Mcl-1's degradation by the ubiquitin-dependent proteasome degradation pathway. The role of TCTP in modulating Mcl-1's stability and antiapoptotic activity is discussed.
MATERIALS AND METHODS
Yeast two-hybrid screen. PBTM116mMcl-1⌬C31 and PBTM116hMcl-1⌬C27 are two yeast expression vectors that could direct the synthesis of a fusion protein containing the LexA-binding domain and the mouse or human Mcl-1 protein without the C-terminal transmembrane domain (mMcl-1⌬C31 and hMcl-1⌬C27). These two vectors were used as bait to screen human lymphocyte and mouse embryonic day 7 cDNA libraries according to the manufacturer's instructions (Clontech). All positive clones were processed to recover the plasmid containing the library cDNAs, and the recovered plasmids were reintroduced into the yeast strain L40 transformed with the bait vector to confirm their positivity before their sequence was analyzed by the standard method.
Antibodies. Mouse Mcl-1-specific polyclonal antibodies were generated in rabbits by using bacterially produced, histidine-tagged mMcl-1⌬C31 protein.
TCTP-specific polyclonal antibodies were generated in guinea pigs by using recombinant TCTP⌬N10. For most immunoprecipitation and immunoblotting analyses, partially purified rabbit or guinea pig sera were used. For immunocolocalization experiments, both TCTP and mMcl-1 antibodies were first affinity purified by using specific antigens cross-linked to CNBr-activated Sepharose (Amersham). Other antibodies used in the present study include those specific to hMcl-1, Bcl-2, Bax, ubiquitin, and green fluorescent protein (GFP; all from Santa Cruz Biotechnology); p53 (a gift from Young-Sun Lin, IBMS, Academia Sinica, Taipei, Taiwan); and ␣-tubulin (Sigma).
Cells. NIH 3T3 is a mouse fibroblast cell line and was purchased from the American Type Culture Collection. CHOP is a Chinese hamster ovary cell line stably transfected with the polyomavirus large T antigen (9a) and was kindly provided by James W. Dennis (Mt. Sinai Hospital, Toronto, Ontario, Canada). Ba/F3 is a murine interleukin-3 (IL-3)-dependent pro-B-call line, and Ba/F3/ hMcl-1 cells are Ba/F3 derivatives stably overexpressing the human Mcl-1 protein as previously described (30) . Ba/F3hMcl-1/TCTP cells (clones T-20 and T-23) are Ba/F3/hMcl-1 (clone #23H) derivatives stably overexpressing FLAG-TCTP, whereas the Ba/F3hMcl-1/vector cells (clones V-13 and V-14) are the parental Ba/F3/hMcl-1 cells (clone #23H) stably transfected with an empty vector. Ba/ F3/mMcl #Wt-34 and #Wt-38 are two representative clones of Ba/F3 derivatives stably overexpressing the hemagglutinin (HA)-tagged wild-type mMcl-1 protein. Ba/F3/E206R, Ba/F3/K257V and Ba/F3/K260V are all Ba/F3 derivatives stably overexpressing the HA-tagged mMcl-1 mutants with a single amino acid mutation at the position as indicated in their names. All Ba/F3 derivatives were generated by transfection of cells with respective expression vectors by electroporation as previously described (6) . To analyze the viability of the Ba/F3 derivatives after deprivation of IL-3, cells were seeded at a density of 10 5 /ml in RPMI 1640 medium supplemented with 10% fetal bovine serum and 10 U of recombinant IL-3/ml. At 2 days after seeding, cells were washed three times with phosphate-buffered saline (PBS) and seeded in low-serum (0.5%) medium without IL-3. Cell viability was determined by the trypan blue exclusion analysis. In some cases, the annexin V staining kit (BioVision) was used to quantify the relative number of cells that had undergone apoptosis.
Expression vectors. pCDNA3-HA-mMcl-1, pCDNA3-HA-hMcl-1, pCDNA3-BID, pCDNA3-Bad, pCDNA3-Bcl-2, pCDNA3-A1, pCDNA3-HA-AKT, pCDNA3-HA-PU.1, pCDNA-FLAG-Bim, and pCDNA3-p53 are mammalian expression vectors for expressing various proteins as indicated in the construct names. pFLAG-CMV2-TCTP was generated by PCR amplification of the coding region of the mouse TCTP cDNA with two primers (sense, 5Ј-CCCAAGCTTA TCATCTACCGGGACCTCATCAGCCATGACGAGCTGTTCTCCGAC-3Ј; antisense, 5Ј-GATCGGATCCTTAACATTTCTCCATCTCTAAGCC-3Ј). The amplified fragments were restricted with HindIII and BamH1 and cloned into the corresponding sites of the pFLAG-CMV2 vector (Kodak). pGEX4T-1-TCTP⌬N10 is a bacterial expression vector which directs the synthesis of a TCTP mutant (without the first 10 amino acids) C-terminally fused to the glutathione S-transferase (GST) protein. Triton X-100, 0.5 mM phenylmethylsulfonyl fluoride, 5 g of leupeptin/ml, 10 g of aprotinin/ml), the bound proteins were resolved on a sodium dodecyl sulfate (SDS)-containing 10% polyacrylamide gel and visualized by fluorography.
Coimmunoprecipitation (co-IP) of TCTP and mMcl-1. CHOP cells were transiently transfected with wild-type or mutant mMcl-1 mammalian expression vectors, together with pFLAG-CMV2-TCTP, by the liposome-mediated gene transfer method as previously described (17) . At 18 h after transfection, cells were lysed with an ice-cold lysis buffer (10 mM HEPES [pH 7.2], 142.5 mM KCl, 5 mM MgCl 2 , 1 mM EGTA, 0.2%NP-40, 1 mM phenylmethylsulfonyl fluoride, 5 g of leupeptin/ml, and 10 g of aprotinin/ml). Precleared cell lysates were then immunoprecipitated with partially purified antiserum specific to TCTP, mMcl-1, or the corresponding preimmune serum. The immunoprecipitated protein complexes were resolved by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to the polyvinylidene difluoride membrane (Millipore), and the coimmunoprecipitated proteins were analyzed by immunoblotting with anti-HA (Boehringer Mannheim), anti-FLAG M2 (Sigma), or other antibodies as indicated in the figures. After probing with an appropriate horseradish peroxidase-conjugated secondary antibody, specific signals on the membrane were visualized by using an enhanced chemiluminescence system (Amersham) according to the manufacturer's instructions. To analyze the interaction between endogenous TCTP and Mcl-1, the procedure described above was used except that the NIH 3T3 cell lysates were used in the assay.
Indirect immunofluorescence and confocal microscopy. To determine the cellular localization of Mcl-1 and TCTP, NIH 3T3 cells, cultured on coverslips, were fixed in 2% paraformaldehyde in PBS for 15 min. After a brief rinse with PBS at room temperature, cells were blocked and permeabilized in PBS containing 2% goat serum, 0.1% saponin, and 0.02% NaN 3 for 15 min. The cells were then incubated at room temperature with affinity-purified rabbit anti-mouse Mcl-1 and guinea pig anti-mouse TCTP antibodies (5 g/ml each in PBS containing 3% bovine serum albumin). Two hours after incubation, cells were washed with PBS and then incubated with fluorescein-conjugated goat anti-rabbit and Alexa Fluor 568-conjugated goat anti-guinea pig immunoglobulin G (IgG; Molecular Probes) for an additional 1 h at room temperature. After three washes with PBS, stained cells were analyzed with confocal fluorescence microscopy (Zeiss type LSM-5). To show the specificity of the stained signals, cells to be analyzed were processed in an identical way except that the primary antibody used in the staining procedure was preblocked with specific antigen produced in bacterial cells.
Knockdown of TCTP expression with small interfering RNA (siRNA). To knock down TCTP expression in the human cell lines, two TCTP siRNA-expressing vectors (siTCTP#1 and siTCTP#2) were constructed by using the pSUPER-neoϩgfp vector (OligoEngine, Inc.). These two constructs were designed according to the manufacturer's protocol in such a way that a duplex siRNA corresponding to the following two regions of the human TCTP gene 5Ј-AAGGTACCGAAAGCACAGT-3Ј(siTCTP#1) or 5Ј-AACCATCACCTGC AGGAAA-3Ј (siTCTP#2) could be synthesized inside mammalian cells transfected with these vectors (4) .
RESULTS
Interaction between Mcl-1 and TCTP. We sought here initially to identify cellular factors that might bind to Mcl-1 and modulate Mcl-1's activity. By using the yeast two-hybrid approach with Mcl-1 as bait (see Materials and Methods), several candidate molecules were identified. Two of these candidates turned out to be Bcl-2 family members (Bax and Bik) that were already reported to be able to interact with Mcl-1 in either mammalian or yeast cells (9b, 32) . We first characterized, among many other candidates that were identified in our twohybrid screen, the clone that encodes the mouse homolog of the human TCTP protein. Sequence analysis revealed that we had selected out two independent groups of TCTP cDNA clones. One would encode a truncated protein from amino acids 11 to 172 and the other from amino acids 14 to 94 (Fig.  1A) .
We next carried out the following experiments to validate the specific interaction between Mcl-1 and TCTP. First, the in vitro GST pull-down assay was performed. As shown in Fig.  1B , the [
35 S]methionine-labeled Mcl-1 protein synthesized by the in vitro transcription-translation system was efficiently and specifically pulled down by the GST-TCTP⌬N10 fusion protein (Fig. 1B, upper panel, lane 2) . The observed in vitro binding activity of this fusion protein to Mcl-1 was specifically mediated by the TCTP moiety, since Mcl-1 was not pulled down by the GST protein alone. (Fig. 1B, upper panel, lane 3) . The specific in vitro interaction between Mcl-1 and TCTP was also observed with the GST-Mcl-1 fusion protein and [
35 S]methionine-labeled, in vitro-synthesized TCTP⌬N10 (Fig. 1B , middle panel, lane 3). Interestingly, in this in vitro binding assay, unlike TCTP⌬N10, the full-length TCTP protein did not manifest any significant binding to Mcl-1 (compare the middle and the bottom panels of Fig. 1B, lanes 3) .
Next, the in vivo interaction between Mcl-1 and TCTP was examined by a co-IP assay. In this assay, CHOP cells were transiently transfected with expression vectors encoding HAtagged mMcl-1 (HA-mMcl-1) and FLAG-tagged full-length TCTP (FLAG-TCTP). As shown in Fig. 1C , immunoprecipitation of cell lysates containing HA-mMcl-1 and FLAG-TCTP (see Fig. 1C , lanes 1 and 4, for protein expression) with antimMcl-1, but not the preimmune serum, coimmunoprecipitated FLAG-TCTP as revealed by immunoblotting with anti-FLAG antibody (Fig. 1C, compare lanes 2 and 3) . In a reciprocal experiment, the TCTP antibody also specifically coimmunoprecipitated HA-mMcl-1 (Fig. 1C, lane 5) . Next, we examined whether the interaction between Mcl-1 and TCTP could be observed at endogenous levels of both proteins. For this experiment, co-IP assays with lysates from NIH 3T3 cells were performed. As shown in Fig. 1D , the purified mMcl-1 antibody, but not control rabbit IgG, coimmunoprecipitated endogenous TCTP (Fig. 1D, compare lanes 2 and 3) . Also, in a reciprocal co-IP experiment, the mMcl-1 protein was found to be present in the immune complexes pulled down by the TCTP but not by the control guinea pig IgG (Fig. 1D, compare lanes 4 and 5) . Lastly, the in vivo interaction between endogenous mMcl-1 and TCTP was further supported by an immunocolocalization experiment with affinity-purified antibodies specific to mMcl-1 and TCTP. As shown in Fig. 1E , the mMcl-1 protein is predominantly localized in the cytoplasm with a punctate staining structure. However, in some cells it is also found localized in the nucleus (Fig. 1Eb) . Interestingly, no matter where mMcl-1 resides, the TCTP protein is only partially colocalized with mMcl-1, with some cells more prominent than others ( results demonstrate that, in contrast to the negative interaction as observed in the GST pull-down assay (Fig. 1B , the bottom panel), full-length TCTP and mMcl-1 did interact with each other in vivo ( Fig. 1C and D) , albeit probably in a cell statespecific manner (see Discussion). Our results also suggest that additional cellular protein(s) might potentially be involved in mediating the TCTP and Mcl-1 interaction inside the cells. TCTP enhances the protein stability of Mcl-1 but not vice versa. While performing the transient cotransfection experiments for analysis of the in vivo interaction between Mcl-1 and TCTP (Fig. 1C) , we noticed that as we increased the amounts of TCTP-encoding plasmids in the transfection experiment, the protein levels of coexpressed HA-Mcl-1 elevated in a dosedependent manner, despite the fact that equal amounts of HA-Mcl-1-expressing plasmids were used (Fig. 2A, compare  lanes 1 to 4) . Such TCTP-mediated enhancing effect toward intracellular Mcl-1 levels was specific, since levels of other examined proteins, such as HA-PU.1 ( Fig. 2A, lanes 5 to 8) , HA-AKT (Fig. 2B), and p53 (Fig. 2C) , remained unchanged or marginally affected under identical experimental conditions. Conversely, in a reciprocal experiment with increasing amounts of the HA-mMcl-1 expression vector, we failed to observe any enhanced expression of coexpressed FLAG-TCTP (Fig. 2D) . At higher dosages, overexpression of HA-Mcl-1 even inhibited the expression of coexpressed FLAG-TCTP (Fig. 2D, lane 4) . Hence, this modulatory effect on protein levels seems to be unidirectional. Fig. 2A and 3A could be either due to enhanced protein synthesis or inhibition of protein degradation or both. To distinguish these possibilities, we first carried out a pulse-labeling experiment to examine whether TCTP would enhance synthesis of Mcl-1. In this experiment, control Ba/F3hMcl-1 cells (clone V-14) or those stably overexpressing TCTP (clone T-20) were pulse-labeled with [ 35 S]methionine for 30 min before the cell lysates were analyzed by immunoprecipitation with antimouse Mcl-1 antibody, which also cross-reacts with the human homolog of Mcl-1. As shown in Fig. 4A , although the steadystate levels of Mcl-1 (mouse or human) was elevated in the TCTP-overexpressing lines (Fig. 3A) , the synthesis rate of Mcl-1 in these cells as reflected from the amounts of 35 Slabeled band was not significantly different from those cells transfected with the empty expression vector (Fig. 4A , compare lanes 1 and 2). These results indicate that TCTP does not increase Mcl-1's steady-state levels via enhancing Mcl-1's protein synthesis rate. We next examined whether this modulation effect was at the protein stability level. To address this issue, CHOP cells were transiently transfected with HA-mMcl-1 in combination with FLAG-TCTP (Fig. 4B, lanes 1 to 6) or control expression vectors (Fig. 4B, lanes 7 to 12) . A GFP expression vector was also included in this assay to monitor the transfection efficiency among samples. At 18 h after transfection, transfected cells were treated with cycloheximide to inhibit any further protein synthesis. At different time points after cycloheximide treatment, cell lysates were prepared and analyzed by immunoblotting with antibodies specific to the HA-tag (for detection of HA-mMcl-1), the FLAG-tag (for detection of FLAG-TCTP), or GFP. As shown in Fig. 4B and C, under such experimental conditions, the Mcl-1 protein in cells overexpressing TCTP had a half-life of ca. 4.5 h, which was much longer than those in cells transfected with an empty expression vector (ϳ1.5 h). Taken together, these results indicate that TCTP enhances the accumulation of Mcl-1 protein levels through increasing the protein stability of Mcl-1.
Knockdown expression of TCTP destabilizes Mcl-1. Ectopic overexpression of TCTP enhanced the protein stability of Mcl-1. We next examined whether decreased expression of TCTP would destabilize Mcl-1. To address this issue, we established a few stable HeLa cell lines whose TCTP levels were markedly downregulated by siRNA specific to the human TCTP gene (see Materials and Methods). The stability of Mcl-1 in all established TCTP knockdown lines were very similar, and the results of two representative clones are demonstrated in Fig. 5 . As shown in this figure, after treatment of the cells with cycloheximide, the endogenous hMcl-1 levels decreased with a half-life of ca. 45 min in both TCTP knockdown lines, siTCTP1-7 and siTCTP2-3, which was significantly shorter than the half-life observed for the control cells (ϳ1.5 h). In contrast, under the same experimental conditions, the protein levels of two other TCTP noninteracting Bcl-2 family proteins (Bcl-2 and Bax, see mutants with deletion of various N, C, or internal domains. However, most of these mutants, except for the two with deletions of ca. 30 amino acids at the N or C terminus, were expressed at a level that was too low to be detected in our co-IP experiment (data not shown). We therefore sought a different approach. We first examined whether TCTP also interacted with other Bcl-2 family members. Using GST pull-down assays, we demonstrated that among the Bcl-2 family proteins tested as indicated in Fig. 6A only A1 interacted with TCTP. The inability of BID, Bax, Bad, and Bcl-2 to associate with TCTP indicated that the interaction between TCTP and Mcl-1 (as well as A1) was unlikely to be mediated through the highly conserved Bcl-2 homology (BH) domains present in Mcl-1 (or A1). We therefore reasoned that there must be unique sequence information shared by Mcl-1 and A1 that served as a critical structural determinant in mediating the interaction with TCTP. To help identify TCTP-interacting domain in Mcl-1, we first made a sequence alignment analysis on Mcl-1, A1, and other TCTP noninteracting Bcl-2 members (Fig. 6B) . We then mutated two candidate sites (i.e., E206 and K257 in Mcl-1) that met the following two criteria. First, the primary amino acid sequence was distinctly conserved between Mcl-1 and A1 but not among other Bcl-2 family proteins analyzed here. Second, the position of the candidate site was within a loop region, a rather relaxed structure that was more likely to be accessible for protein-protein interaction. As controls, we also mutated a few other neighboring sites that did not meet either or both of the aforementioned criteria (e.g., T240 and K260). Although mutation of E206 and the two sites selected as controls (i.e., T240 and K260) did not affect Mcl-1's binding affinity to TCTP (Fig. 6C) , mutation of K257 to a valine residue (the same residue found in Bcl-2) markedly decreased the TCTP binding affinity of Mcl-1 (Fig. 6C, lane 11) . Notably, the K257V mutant still retained the ability to interact with Bim and Bax, two known Mcl-1 interacting proteins (25, 32) ( Fig.  6D and E, compare lanes 2 and 5). This result further suggests that mutation of K257 into a valine residue does not exert a global conformational change on the Mcl-1 protein itself, and therefore this residue is likely to reside in an important TCTPinteracting domain.
We next compared the protein stability of the K257V mutant to that of the wild-type or other Mcl-1 mutants whose TCTP binding activity was not significantly compromised. We noticed that the turnover rate of all TCTP binding-competent Mcl-1 mutants (only analysis of K260V was shown in Fig. 7 ) was comparable to that of the wild-type protein (t 1/2 , ϳ1.5 h), whereas the TCTP binding-defective mutant K257V manifested a much shorter half-life (ϳ40 min). Interestingly, only the antiapoptotic activity of the TCTP binding-defective mutant (i.e., K257V) and not that of other TCTP binding-competent mutants was significantly compromised (Fig. 8 and data not shown for the T240V and E206R mutants). Taken together, these results indicate that the stability and the antiapoptotic activity of Mcl-1 strongly correlate with Mcl-1's ability to interact with TCTP.
TCTP blocks ubiquitination of Mcl-1. Mcl-1 is eliminated by the ubiquitin-dependent proteasome degradation pathway (24) . We next examined whether TCTP plays any antagonistic role in Mcl-1's degradation process. As shown in Fig. 9 , in the presence of the proteasome inhibitor MG132 the ubiquitinated form of Mcl-1 (UB-Mcl-1) could be detected in cells transiently transfected with the HA-mMcl-1 expression vector (Fig.  9A, lane 1) . Notably, when cells were cotransfected with increasing amounts of the TCTP expression vector the extent of ubiquination of Mcl-1 diminished in a dose-dependent manner (Fig. 9A, compare lanes 1 to 4) . Furthermore, we noticed that the TCTP binding-defective mutant K257V was much more susceptible to ubiquination than the wild-type Mcl-1 protein (Fig. 9B) . Taken together, these results indicate that the susceptibility of Mcl-1 to undergo proteasome-dependent degradation is in a reverse relationship to its ability to interact with TCTP.
DISCUSSION
Mcl-1 is a labile protein with a half-life of ca. 30 to 40 min when measured by the pulse-chase analysis (6, 24) and ca. 1.5 h when measured by the cycloheximide blocking method (Fig. 4B, 5, and 7) . The discrepancy between these two measurements suggests that either Mcl-1's degradation involves another labile protein whose synthesis is sensitive to cycloheximide treatment or Mcl-1 undergoes posttranslational In the results presented here, most endogenous Mcl-1 protein bands were not properly resolved to reveal the three bands (in most cases, we only observe two bands as that shown in Fig. 1D  and 3A) . Although the identity of these multiple forms of Mcl-1 remains to be determined, our preliminary observation seems to indicate that TCTP exerts a differential effect on the turnover rates of these different forms of Mcl-1. More experiments are required to investigate this issue. Given the fact that overexpression of TCTP interferes with Mcl-1's degradation at the ubiquitination step and that the TCTP-binding defective mutant of Mcl-1 (K257V) is much more susceptible to ubiquitination and manifests a compromised antiapoptotic activity, we propose the following two models. First, TCTP may serve as a molecular chaperone of Mcl-1. Without TCTP, the newly synthesized Mcl-1 somehow cannot be properly processed to fold into a mature and functional protein and therefore gets degraded faster. While our work was in progress, we noticed that Zhang et al. reported an interaction between Mcl-1 and TCTP (fortilin) (37) . In that study, the authors demonstrated that TCTP was destabilized when the Mcl-1 protein levels were knocked down by RNAi.
The authors further suggested that Mcl-1 worked as a chaperone of TCTP and stabilized the latter protein, a result that was seemingly opposite to our observations. Under our experimental conditions, we noticed that TCTP was much more stable (t 1/2 Ͼ 6 h) than Mcl-1. If Mcl-1 indeed functions to stabilize TCTP as suggested by Zhang et al. (37) , it means that the cells would have to constantly stimulate the synthesis of the labile Mcl-1 protein so as to maintain the stability of a much more stable protein, such as TCTP, a cellular condition that does not seem to be logically favorable. Based on this argument and the recent structure study where a chaperone function was proposed for the yeast homolog of TCTP (28) (37) . More experiments are certainly required to test these two models.
In addition to Mcl-1, we also identified a novel interaction between TCTP and another Bcl-2 family member, A1 (Fig.  6A) . Although the functional significance of the latter interaction is not clear, we noticed that Mcl-1 and A1 share some molecular characteristics that are unique within the Bcl-2 family. First, they both are immediate-early genes activated by cytokines (6, 12, 16) . Second, both mRNAs are extremely unstable (6, 21) . It would be interesting to determine whether A1 is also a labile protein and whether TCTP also affects its stability and its antiapoptotic activity.
Growth-related functions have been reported for TCTP. However, the underlying mechanisms still remain largely uncharacterized (9) . Recent studies have suggested that the cellular role of TCTP may be partly mediated by its association with factors involved in translation elongation or mitosis/cytokinesis (5, 35) . The newly identified ability of TCTP in modulating the activity of the antiapoptotic protein Mcl-1 (and potentially other related factors) further strengthens TCTP's role in cell growth control. We noticed that, consistent with an indispensable role of TCTP in cell growth, some transfected cells (i.e., GFP-positive cells) underwent autophagy-like morphological changes and subsequently died in the course of selecting stable clones that overexpress the TCTP siRNA (data not shown). For stable clones that we were able to establish for subsequent analysis, we noticed that their TCTP levels were not completely knocked down (at least 10 to 20% of the original levels remained). The growth and morphology of these established clones are apparently not too much different from those of their parental cells (data not shown). This observation suggests that whereas the presence of TCTP is critical for optimal proliferation, residual levels of TCTP may be sufficient to carry out most of its biological activities. Under such conditions, the effect of TCTP on the Mcl-1 stability and function in the established TCTP knockdown lines may be underestimated, as residual amounts of TCTP are still present in these cells. An ultimate proof of the modulatory roles of TCTP on the Mcl-1 protein would require the generation of cells whose TCTP expression is completely inhibited, for example, from cells generated by the gene knockout approach.
The Mcl-1 protein was found localized in both the mitochondrial and the nonmitochondrial membrane fractions (34) . However, despite the absence of a common nuclear localization sequence, one group did report a predominant nuclear localization of Mcl-1 (15, 37) . In our immunofluorescence analysis, we observed that Mcl-1 was predominantly localized in mitochondria when cells were freshly seeded and analyzed on the next day (data not shown). However, if the immunostaining analysis was carried out with cells that had been cultured for a longer time (e.g., at least 2 days after seeding), Mcl-1 was found localized both in nucleus and cytoplasm. In either cellular compartment, we noticed that, whereas Mcl-1 and TCTP were only partially colocalized, such spatial association was more prominent in some cell states than others, suggesting that the interaction of these two proteins is potentially regulated in a cell-state-specific manner. The physiological consequence, as well as the responsible regulatory signaling events, of such cell state-dependent, subcellular translocation of these two proteins is currently not clear and awaits further investigation.
